Drug Discovery and Biomedical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425, United States.
Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas 66160, United States.
J Nat Prod. 2022 Jul 22;85(7):1779-1788. doi: 10.1021/acs.jnatprod.2c00324. Epub 2022 Jul 10.
Oxidative stress plays an important role in acetaminophen (APAP)-induced hepatotoxicity. Platanosides (PTSs) isolated from the American sycamore tree () represent a potential new four-molecule botanical drug class of antibiotics active against drug-resistant infectious disease. Preliminary studies have suggested that PTSs are safe and well tolerated and have antioxidant properties. The potential utility of PTSs in decreasing APAP hepatotoxicity in mice in addition to an assessment of their potential with APAP for the control of infectious diseases along with pain and pyrexia associated with a bacterial infection was investigated. On PTS treatment in mice, serum alanine aminotransferase (ALT) release, hepatic centrilobular necrosis, and 4-hydroxynonenal (4-HNE) were markedly decreased. In addition, inducible nitric oxide synthase (iNOS) expression and c-Jun--terminal kinase (JNK) activation decreased when mice overdosed with APAP were treated with PTSs. Computational studies suggested that PTSs may act as JNK-1/2 and Keap1-Nrf2 inhibitors and that the isomeric mixture could provide greater efficacy than the individual molecules. Overall, PTSs represent promising botanical drugs for hepatoprotection and drug-resistant bacterial infections and are effective in protecting against APAP-related hepatotoxicity, which decreases liver necrosis and inflammation, iNOS expression, and oxidative and nitrative stresses, possibly by preventing persistent JNK activation.
氧化应激在对乙酰氨基酚(APAP)诱导的肝毒性中起着重要作用。从美国梧桐树上分离得到的北美朴苷(PTSs)代表了一种潜在的新的四分子植物药抗生素类别,对耐药性传染病具有活性。初步研究表明,PTSs 安全且耐受良好,具有抗氧化特性。除了评估 PTSs 与 APAP 联合控制传染病以及与细菌感染相关的疼痛和发热的潜力外,还研究了 PTSs 降低小鼠 APAP 肝毒性的潜力。在 PTS 治疗的小鼠中,血清丙氨酸氨基转移酶(ALT)释放、肝中央小叶坏死和 4-羟壬烯醛(4-HNE)明显减少。此外,当用 PTSs 治疗过量 APAP 的小鼠时,诱导型一氧化氮合酶(iNOS)表达和 c-Jun-N 末端激酶(JNK)激活减少。计算研究表明,PTSs 可能作为 JNK-1/2 和 Keap1-Nrf2 抑制剂发挥作用,并且异构混合物可能比单个分子更有效。总的来说,PTSs 代表有希望的植物药,可用于肝保护和耐药性细菌感染,并且有效预防与 APAP 相关的肝毒性,降低肝坏死和炎症、iNOS 表达以及氧化和硝化应激,可能通过防止持续的 JNK 激活。